Suppliers / Foshan Nanhai Zhongnan Pharmaceutical Factory

Foshan Nanhai Zhongnan Pharmaceutical Factory

China Updated 9 July 2026

Foshan Nanhai Zhongnan Pharmaceutical Factory is an API manufacturer based in China. It holds one active US drug master file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 6 September 2024 as VAI.

1
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 6 September 2024 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3027690779

What they file, and where

Molecule Regulators Docs
Methyl Salicylate US FDA 1

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 1

Questions about Foshan Nanhai Zhongnan Pharmaceutical Factory

Does Foshan Nanhai Zhongnan Pharmaceutical Factory hold a US DMF or a CEP?
Foshan Nanhai Zhongnan Pharmaceutical Factory holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Foshan Nanhai Zhongnan Pharmaceutical Factory FDA-registered?
One site operated by Foshan Nanhai Zhongnan Pharmaceutical Factory carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Foshan Nanhai Zhongnan Pharmaceutical Factory's last inspection go?
The most recent inspection on record closed on 6 September 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Foshan Nanhai Zhongnan Pharmaceutical Factory manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does Foshan Nanhai Zhongnan Pharmaceutical Factory make?
1 molecule is on record against Foshan Nanhai Zhongnan Pharmaceutical Factory, including Methyl Salicylate. Each links through to that molecule's full manufacturer list.
Which regulators recognise Foshan Nanhai Zhongnan Pharmaceutical Factory's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Foshan Nanhai Zhongnan Pharmaceutical Factory?

Ask Fred what the record holds on Foshan Nanhai Zhongnan Pharmaceutical Factory, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Open risk flags

  • The most recent inspection outcome was VAI, on 6 September 2024.

Comparable suppliers

Acrobiosystems also in China AMHWA Biopharm Co.,Ltd also in China Anhui Apeloa Biotechnology also in China Anqui Lu'an Pharmaceutical Co.,Ltd also in China Argus Pharmaceuticals also in China

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates